From newly diagnosed to long-standing diabetes, our bilingual primary care team provides A1c monitoring, evidence-based medication management, lifestyle coaching, and complication screening, all in one place.
Schedule Your VisitType 2 diabetes is a chronic condition, but with the right management it does not have to be a sentence to declining health. Modern medications, continuous glucose monitoring, and proven lifestyle interventions allow most patients to live full, active lives with a normal lifespan.
According to the CDC, over 37 million Americans have diabetes, and Hispanic populations face nearly 60% higher rates than non-Hispanic whites. Our bilingual primary care providers in Westchester offer culturally informed care that fits Miami's diverse community.
We coordinate every aspect of your diabetes care, medication, A1c trending, kidney function, eye and foot exam referrals, cardiovascular risk reduction, and mental health support.
In-office point-of-care A1c testing every 3 months until at goal, then every 6 months.
Personalized choice of metformin, GLP-1 agonists (Ozempic, Mounjaro), SGLT-2 inhibitors, DPP-4 inhibitors, and insulin when needed.
Support and interpretation for CGM (Dexcom, Libre) to fine-tune treatment between visits.
Microalbumin and eGFR yearly to catch diabetic kidney disease early.
Annual ophthalmology and podiatry referrals to prevent retinopathy and foot ulcers.
Joint management of cholesterol and blood pressure, diabetes triples cardiovascular risk.
First-line therapy for nearly all newly diagnosed patients. Reduces liver glucose production, improves insulin sensitivity, and is associated with cardiovascular benefits.
Powerful new options that lower A1c, reduce cardiovascular events, and produce significant weight loss. Game-changers for patients with obesity and diabetes.
Lower blood sugar, blood pressure, and provide kidney and heart protection, even in patients without diabetes.
For patients whose A1c remains elevated despite oral medications, we provide insulin starts, dose titration, and pen/pump support.
Through weight loss counseling, even modest weight loss (5 to 10%) significantly improves A1c and may reduce medication needs.
Most adults: under 7%. Tighter (under 6.5%) for younger healthy patients. Relaxed (under 8%) for older patients with comorbidities.
Every 3 months if not at goal or treatment has changed. Every 6 months when stable.
Sometimes, with significant weight loss (often 10 to 15%) or bariatric surgery, especially in newly diagnosed patients.
Cardiovascular disease, kidney damage, neuropathy, retinopathy, foot ulcers, skin infections, all dramatically reduced by good A1c control.
Not necessarily. Modern oral and injectable non-insulin medications (GLP-1s, SGLT-2s) keep many patients off insulin for years.
Establish ongoing care with a primary provider who knows your history.
Call (305) 676-8217In-depth articles from our medical team to help you make informed decisions.
